New combo therapy shows promise for lung cancer patients with brain tumors
NCT ID NCT07491211
First seen Mar 26, 2026 · Last updated May 06, 2026 · Updated 4 times
Summary
This study looks at 300 adults with a specific type of advanced lung cancer (EGFR mutation) that has spread to the brain and causes symptoms. Patients received a targeted pill (osimertinib) plus focused radiation to the brain. The goal is to see if this combination helps control the cancer longer and improves survival. This is a real-world study using medical records from multiple hospitals.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC (ADVANCED NON-SMALL CELL LUNG CANCER) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fudan University Shanghai Cancer Center
Shanghai, China, 200032, China
-
Shanghai Jiao Tong University Affiliated Chest Hospital
Shanghai, China
-
Wuhan Tongji Hospital
Wuhan, Hubei, China
Conditions
Explore the condition pages connected to this study.